Age at time of high-resolution computed tomography (HRCT), years |
50 ± 12 |
Sex, woman |
216 (82) |
Body mass index, kg/m2
|
29 ± 6 |
Ethnicity, white |
192 (73) |
Smoker, current or former |
97 (37) |
Alcohol, current |
96 (46) |
Proton pump inhibitor use, current |
171 (65) |
SSc disease subtype |
|
Diffuse cutaneous |
129 (49) |
Limited cutaneous |
131 (49) |
Sine scleroderma |
5 (2) |
Years since first non-Raynaud SSc symptom to HRCT date |
6 ± 11 |
Systemic sclerosis specific antibodies, positive |
|
Anti-topoisomerase I (Scl-70) |
78 (30) |
Anticentromere (ACA) |
48 (18) |
Anti RNA polymerase III |
59 (23) |
Modified Rodnan skin score |
13 (11) |
Radiographic interstitial lung disease present |
188 (71) |
Forced vital capacity (FVC) % predicted |
76 (18) |
Diffusing capacity for carbon monoxide (DLCO) % predicted |
60 (20) |